Dose escalation of TAS-117 in patients with advanced solid tumors

被引：0
|
作者：
Rodon, J. [1 ]
Arkenau, H-T. [2 ]
Funchain, P. [3 ]
Hervieu, A. [4 ]
Gao, L. [5 ]
Liu, M. [6 ]
Halim, A. [7 ]
Mina, M. [8 ]
Takahashi, O. [8 ]
Benhadji, K. [8 ]
Delaloge, S. [9 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Houston, TX USA
[2] Sarah Cannon Res Inst, Onocl, London, England
[3] Cleveland Clin, Dept Hematol & Med Oncol, Cleveland, OH USA
[4] Ctr Georges Francois Leclerc, Med Oncol, Dijon, France
[5] Taiho Oncol Inc, Dept Clin Pharmacol & Pharmacometr, Princeton, NJ USA
[6] Taiho Oncol Inc, Biostat, Princeton, NJ USA
[7] Taiho Oncol Inc, Biomarkers & Compan Diagnost, Princeton, NJ USA
[8] Taiho Oncol Inc, Clin Dev, Princeton, NJ USA
[9] Inst Gustave Roussy, Intercept Med Sci Programme, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
467P
引用
收藏
页码：S754 / S755
页数：2
相关论文
共 50 条
  • [31] A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors
    Padda, Sukhmani K.
    Krupitskaya, Yelena
    Chhatwani, Laveena
    Fisher, George A.
    Colevas, Alexander D.
    Pedro-Salcedo, Melanie San
    Decker, Rodney
    Latz, Jane E.
    Wakelee, Heather A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 1013 - 1020
  • [32] A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors
    Andrea Wang-Gillam
    Susanne M. Arnold
    Ronald M. Bukowski
    Mace L. Rothenberg
    Wendy Cooper
    Kenneth K. Wang
    Eric Gauthier
    A. Craig Lockhart
    Investigational New Drugs, 2012, 30 : 266 - 272
  • [33] A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors
    Zacharenia Saridaki
    Periklis Pappas
    John Souglakos
    Martha Nikolaidou
    Nikolaos Vardakis
    Athanasios Kotsakis
    Marios Marselos
    Vassilis Georgoulias
    Dimitris Mavroudis
    Cancer Chemotherapy and Pharmacology, 2009, 65 : 121 - 128
  • [34] A Dose Escalation Trial of Biweekly Docetaxel and Gemcitabine with Filgrastim or Pegfilgrastim for the Treatment of Patients with Advanced Solid Tumors
    Dragnev, Konstantin H.
    Hardin, Steven B.
    Pipas, J. Marc
    Davis, Thomas H.
    Rigas, James R.
    CHEMOTHERAPY, 2010, 56 (02) : 135 - 141
  • [35] A Phase I dose-escalation study of afatinib combined with nintedanib in patients with advanced solid tumors
    Gordon, Michael S.
    Springett, Gregory M.
    Su, Yungpo Bernard
    Ould-Kaci, Mahmoud
    Wind, Sven
    Zhao, Yihua
    LoRusso, Patricia M.
    FUTURE ONCOLOGY, 2015, 11 (10) : 1479 - 1491
  • [36] A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors
    Harding, James J.
    Telli, Melinda
    Munster, Pamela
    Voss, Martin H.
    Infante, Jeffrey R.
    DeMichele, Angela
    Dunphy, Mark
    Le, Mai H.
    Molineaux, Chris
    Orford, Keith
    Parlati, Frank
    Whiting, Sam H.
    Bennett, Mark K.
    Tannir, Nizar M.
    Meric-Bernstam, Funda
    CLINICAL CANCER RESEARCH, 2021, 27 (18) : 4994 - 5003
  • [37] A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors
    Wang-Gillam, Andrea
    Arnold, Susanne M.
    Bukowski, Ronald M.
    Rothenberg, Mace L.
    Cooper, Wendy
    Wang, Kenneth K.
    Gauthier, Eric
    Lockhart, A. Craig
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 266 - 272
  • [38] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Robert, Francisco
    Sandler, Alan
    Schiller, Joan H.
    Liu, Glenn
    Harper, Karen
    Verkh, Lev
    Huang, Xin
    Ilagan, Jennifer
    Tye, Lesley
    Chao, Richard
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
  • [39] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
    Francisco Robert
    Alan Sandler
    Joan H. Schiller
    Glenn Liu
    Karen Harper
    Lev Verkh
    Xin Huang
    Jennifer Ilagan
    Lesley Tye
    Richard Chao
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 669 - 680
  • [40] A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors
    Sukhmani K. Padda
    Yelena Krupitskaya
    Laveena Chhatwani
    George A. Fisher
    Alexander D. Colevas
    Melanie San Pedro-Salcedo
    Rodney Decker
    Jane E. Latz
    Heather A. Wakelee
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1013 - 1020
12345